Dassault Systèmes examines failures in CAPA and quality systems

Quality management systems, particularly Corrective and Preventive Action (CAPA) processes in life sciences and medical device organizations, often focus on closing records rather than achieving genuine learning. While organizations may meet metrics related to cycle times and on-time closure rates, these indicators frequently fail to reflect actual risk reduction.

Issues arise when investigations are poorly defined or when root cause analysis addresses symptoms instead of underlying drivers. This leads to a cycle where systemic problems remain invisible until they result in regulatory findings, delayed product releases, or reputational damage. Because data is often siloed within individual closed records, investigators struggle to identify patterns across different sites, equipment, or timeframes.

To improve effectiveness, leadership is encouraged to move beyond process throughput metrics. Instead, organizations should track recurrence rates, systemic impact, and actual risk reduction to ensure that quality systems drive continuous improvement rather than mere compliance.